Screener
Arcutis Biotherapeutics, Inc. ARQT Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 34,770 | 21,079 |
| Total current assets | 467,671 | 411,232 |
| Property, plant, and equipment, net | 872 | 1,043 |
| Intangible assets, net | 13,687 | 14,812 |
| Operating lease right-of-use asset | 4,253 | 4,467 |
| Other assets | 2,054 | 1,419 |
| Total assets | $488,537 | $432,973 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s intangibles (net)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported intangibles (net) of $13.69M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s intangibles (net) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s intangibles (net) decreased by 14.1% year-over-year, from $15.94M to $13.69M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s intangibles (net) has grown at a 52.8% compound annual growth rate (CAGR), from $1.78M to $14.81M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Arcutis Biotherapeutics, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude